Scientific publications

October 2025
Micvotabart pelidotin induces immunogenic cell death markers and activates tumor immune cells in pre-clinical studies – Abstract Number: A112
AACR-NCI-EORTC Poster
October 2025
Micvotabart pelidotin, an ADC targeting non-cellular EDB+FN, induces an immune response in tumors from participants in a phase 1 dose escalation study – Abstract Number: A114
AACR-NCI-EORTC Poster
October 2025
Characterization of micvotabart pelidotin target binding properties and extracellular payload release – Abstract Number: A116
AACR-NCI-EORTC Poster
October 2025
Development of multiplex immunofluorescence workflows for characterizing tumor-immune and stromal compartments for pharmacodynamic assessments of solid tumors – Abstract Number: A117
AACR-NCI-EORTC Poster
October 2025
Mouse analog of micvotabart pelidotin sensitizes a refractory syngeneic breast cancer model to anti-PD1 therapy – Abstract Number: A115
AACR-NCI-EORTC Poster
October 2025
Micvotabart pelidotin, a non-cellular targeting ADC, remodels the tumor microenvironment in tumors from participants in a phase 1 dose escalation study – Abstract Number: A113
AACR-NCI-EORTC Poster
October 2025
A Phase 1/2 Study of a First-in-Class Non-Cellular Antibody-Drug Conjugate, Micvotabart Pelidotin (MICVO), in Combination with Pembrolizumab in Select Advanced Solid Tumors – Abstract Number: 1025
ESMO Poster
October 2025
Phase 1 Expansion Study of the First-in-Concept Extracellular Antibody-Drug Conjugate (ADC), Micvotabart Pelidotin (MICVO), in Patients with Select Advanced Solid Tumors – Abstract Number: 1031
ESMO Poster
October 2025
Histological biomarker analysis of nonclinical and baseline tumor samples from the phase 1 dose escalation study using micvotabart pelidotin (MICVO) in advanced solid tumors – Abstract Number: 1014
ESMO Poster
October 2025
First-in-Human Study of the First-in-Class Non-cellular Targeting Antibody-Drug Conjugate (ADC), Micvotabart Pelidotin (MICVO), in Patients With Select Solid Tumors – Abstract Number: 965
ESMO Poster